Overview
Synopsys, Inc., based in the United States, operates primarily within the electronic design automation (EDA) industry, which is integral to developing electronic systems and circuits. The company is a leader in providing software products and services used to design and create integrated circuits, offering solutions that encompass the entire design process from concept to validation. Synopsys also delves into programming design and development, with significant initiatives in software quality and security testing, which are critical in today’s technology-driven markets. Additionally, the firm has expanded its reach through strategic acquisitions, consistently enhancing its semiconductor IP portfolio and strengthening its market position in strategic, fast-growing areas like artificial intelligence, automotive electronics, and internet of things (IoT).
Basic Stats
The share price of Synopsys, Inc. as of September 5, 2025 is €523.20 / share. This is an increase of 1.61% from the prior week. The market cap (or net worth) of Synopsys, Inc. as of September 5, 2025 is €78,519.39 MM.
The Factor Analysis chart (below right) shows a view of Synopsys, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 78,519.39 MM |
| EV | |
| Shares Out. | 155.15 MM |
| Earnings Date | |
| EPS (TTM) | 13.94 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.22 |
| Beta | 0.96 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.19 |
| ROE | 0.28 |
| ROIC | 0.10 |
| CROIC | 0.61 |
| OCROIC | 0.06 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 70.86 /100 |
| Profitability | 75.49 /100 |
| Quality Score | 56.28 /100 |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | 85.74 /100 |
| Analyst Sentiment | |
| Fund Sentiment | 74.56 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Synopsys, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-08-27 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-16 | B of A Securities | Buy | Buy | Maintains |
| 2025-04-15 | Mizuho | Outperform | Outperform | Maintains |
| 2025-04-15 | Keybanc | Overweight | Overweight | Maintains |
| 2025-02-27 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-02-27 | Needham | Buy | Buy | Reiterate |
| 2025-02-27 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-25 | Rosenblatt | Buy | Buy | Maintains |
| 2025-02-24 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-01-13 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-13 | Redburn Atlantic | Buy | Initiate | |
| 2024-12-06 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-12-05 | Baird | Outperform | Outperform | Maintains |
| 2024-12-05 | Needham | Buy | Buy | Reiterate |
| 2024-12-05 | Rosenblatt | Buy | Buy | Maintains |
| 2024-12-04 | Rosenblatt | Buy | Buy | Maintains |
| 2024-11-22 | Wells Fargo | Equal-Weight | Initiate | |
| 2024-11-11 | Loop Capital | Buy | Initiate | |
| 2024-10-24 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-10-22 | Needham | Buy | Buy | Reiterate |
| 2024-10-22 | Mizuho | Outperform | Initiate | |
| 2024-10-15 | Berenberg | Buy | Initiate | |
| 2024-08-23 | Rosenblatt | Buy | Buy | Maintains |
| 2024-08-22 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-08-22 | Baird | Outperform | Outperform | Maintains |
| 2024-08-22 | Needham | Buy | Buy | Reiterate |
| 2024-08-22 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2024-08-15 | Rosenblatt | Buy | Buy | Maintains |
| 2024-07-10 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-07-02 | Baird | Outperform | Outperform | Maintains |
| 2024-06-27 | Keybanc | Overweight | Overweight | Maintains |
| 2024-05-23 | Baird | Outperform | Outperform | Maintains |
| 2024-05-23 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-05-23 | Rosenblatt | Buy | Buy | Maintains |
| 2024-05-23 | Needham | Buy | Buy | Reiterate |
| 2024-05-23 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2024-04-04 | Piper Sandler | Overweight | Initiate | |
| 2024-03-22 | Needham | Buy | Buy | Reiterate |
| 2024-03-21 | Rosenblatt | Buy | Buy | Reiterate |
| 2024-02-22 | Baird | Outperform | Outperform | Maintains |
| 2024-02-22 | Needham | Buy | Buy | Reiterate |
| 2024-02-20 | Rosenblatt | Buy | Buy | Maintains |
| 2023-12-13 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-12-01 | Rosenblatt | Buy | Buy | Maintains |
| 2023-11-30 | Stifel | Buy | Buy | Maintains |
| 2023-11-30 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-11-30 | Needham | Buy | Buy | Maintains |
| 2023-11-30 | Keybanc | Overweight | Overweight | Maintains |
| 2023-11-27 | Stifel | Buy | Buy | Reiterate |
| 2023-11-27 | Keybanc | Overweight | Overweight | Maintains |
| 2023-11-10 | Morgan Stanley | Overweight | Initiate | |
| 2023-10-13 | Keybanc | Overweight | Overweight | Maintains |
| 2023-09-29 | HSBC | Buy | Initiate | |
| 2023-08-23 | Rosenblatt | Buy | Buy | Reiterate |
| 2023-08-17 | Stifel | Buy | Buy | Maintains |
| 2023-08-17 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-08-17 | Needham | Buy | Buy | Reiterate |
| 2023-08-17 | Rosenblatt | Buy | Buy | Maintains |
| 2023-08-17 | Baird | Outperform | Outperform | Maintains |
| 2023-08-17 | Keybanc | Overweight | Overweight | Maintains |
| 2023-08-15 | Needham | Buy | Buy | Reiterate |
| 2023-07-13 | Keybanc | Overweight | Overweight | Maintains |
| 2023-06-05 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-05-18 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-05-18 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-05-18 | Needham | Buy | Buy | Reiterate |
| 2023-05-18 | Rosenblatt | Buy | Buy | Maintains |
| 2023-05-18 | Baird | Outperform | Outperform | Maintains |
| 2023-05-15 | Rosenblatt | Buy | Buy | Reiterate |
| 2023-02-16 | Rosenblatt | Buy | Reiterate | |
| 2023-02-16 | Wells Fargo | Overweight | Maintains | |
| 2023-02-16 | Needham | Buy | Maintains | |
| 2023-02-14 | Rosenblatt | Buy | Reiterate | |
| 2022-12-16 | B of A Securities | Neutral | Buy | Upgrade |
| 2022-12-02 | Rosenblatt | Buy | Maintains | |
| 2022-12-01 | Keybanc | Overweight | Maintains | |
| 2022-11-22 | Wells Fargo | Overweight | Maintains | |
| 2022-11-16 | Edward Jones | Hold | Initiate | |
| 2022-09-29 | Deutsche Bank | Buy | Initiate | |
| 2022-09-08 | Stifel | Buy | Initiate | |
| 2022-08-18 | Baird | Outperform | Maintains | |
| 2022-08-18 | Rosenblatt | Buy | Maintains | |
| 2022-08-18 | Needham | Buy | Maintains | |
| 2022-08-18 | Keybanc | Overweight | Maintains | |
| 2022-08-17 | Wolfe Research | Outperform | Initiate | |
| 2022-08-12 | Rosenblatt | Buy | Maintains | |
| 2022-08-11 | Wells Fargo | Overweight | Maintains | |
| 2022-06-29 | B of A Securities | Underperform | Neutral | Upgrade |
| 2022-05-19 | Needham | Buy | Maintains | |
| 2022-05-19 | Wells Fargo | Overweight | Maintains | |
| 2022-01-10 | Keybanc | Overweight | Maintains | |
| 2021-12-02 | Rosenblatt | Buy | Maintains | |
| 2021-12-02 | Needham | Buy | Maintains | |
| 2021-12-02 | Keybanc | Overweight | Maintains | |
| 2021-12-02 | Wells Fargo | Overweight | Maintains | |
| 2021-11-29 | Credit Suisse | Outperform | Maintains | |
| 2021-11-23 | Wells Fargo | Overweight | Maintains | |
| 2021-10-20 | Needham | Buy | Initiate | |
| 2021-09-17 | B of A Securities | Neutral | Underperform | Downgrade |
| 2021-08-25 | Rosenblatt | Buy | Maintains | |
| 2021-08-19 | Wells Fargo | Overweight | Maintains | |
| 2021-08-19 | Rosenblatt | Buy | Maintains | |
| 2021-08-19 | Keybanc | Overweight | Maintains | |
| 2021-08-12 | Wells Fargo | Overweight | Maintains | |
| 2021-07-15 | WestPark Capital | Buy | Initiate | |
| 2021-06-02 | Rosenblatt | Buy | Initiate | |
| 2021-02-18 | Needham | Buy | Maintains | |
| 2021-02-18 | KeyBanc | Overweight | Maintains | |
| 2021-02-16 | UBS | Buy | Maintains | |
| 2021-02-16 | KeyBanc | Overweight | Maintains | |
| 2021-02-16 | RBC Capital | Outperform | Maintains | |
| 2021-02-10 | Wells Fargo | Overweight | Maintains | |
| 2021-01-19 | Needham | Buy | Maintains | |
| 2021-01-05 | KeyBanc | Overweight | Maintains | |
| 2020-12-03 | Credit Suisse | Outperform | Maintains | |
| 2020-12-03 | Needham | Buy | Maintains | |
| 2020-12-03 | KeyBanc | Overweight | Maintains | |
| 2020-10-14 | UBS | Buy | Maintains | |
| 2020-10-09 | RBC Capital | Outperform | Maintains | |
| 2020-08-20 | Credit Suisse | Outperform | Maintains | |
| 2020-08-20 | KeyBanc | Overweight | Maintains | |
| 2020-08-20 | Needham | Buy | Maintains | |
| 2020-08-20 | RBC Capital | Outperform | Maintains | |
| 2020-06-17 | KeyBanc | Overweight | Maintains | |
| 2020-05-27 | UBS | Buy | Initiate | |
| 2020-05-21 | B of A Securities | Buy | Maintains | |
| 2020-05-21 | Wells Fargo | Overweight | Maintains | |
| 2020-05-21 | JP Morgan | Overweight | Maintains | |
| 2020-05-21 | RBC Capital | Outperform | Maintains | |
| 2020-05-21 | Baird | Outperform | Reiterate | |
| 2020-05-21 | KeyBanc | Overweight | Maintains | |
| 2020-02-21 | CFRA | Buy | Maintains | |
| 2020-02-20 | Credit Suisse | Outperform | Maintains | |
| 2020-02-20 | Needham | Buy | Maintains | |
| 2020-02-20 | Baird | Outperform | Maintains | |
| 2020-02-20 | KeyBanc | Overweight | Maintains | |
| 2020-02-19 | Baird | Outperform | Initiate | |
| 2020-02-14 | Wells Fargo | Overweight | Maintains | |
| 2020-01-10 | KeyBanc | Overweight | Maintains | |
| 2019-12-12 | JP Morgan | Neutral | Overweight | Upgrade |
| 2019-12-05 | KeyBanc | Overweight | Maintains | |
| 2019-08-22 | Wells Fargo | Outperform | Maintains | |
| 2019-08-22 | KeyBanc | Overweight | Maintains | |
| 2019-07-12 | KeyBanc | Overweight | Maintains | |
| 2019-05-15 | Wells Fargo | Outperform | Initiate | |
| 2018-12-06 | Benchmark | Hold | Buy | Upgrade |
| 2018-11-20 | Berenberg | Buy | Initiate | |
| 2018-10-23 | JP Morgan | Underweight | Neutral | Upgrade |
| 2018-08-23 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-05-24 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-05-24 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-02-22 | KeyBanc | Overweight | Overweight | Maintains |
| 2017-12-12 | JP Morgan | Neutral | Underweight | Downgrade |
| 2017-11-30 | KeyBanc | Overweight | Overweight | Maintains |
| 2017-10-25 | RBC Capital | Outperform | Top Pick | Upgrade |
| 2017-08-15 | Credit Suisse | Outperform | Maintains | |
| 2016-10-10 | Buy | Maintains | ||
| 2016-08-18 | Pacific Crest | Overweight | Maintains | |
| 2016-08-18 | KeyBanc | Overweight | Maintains | |
| 2016-06-06 | RBC Capital | Outperform | Initiate | |
| 2015-08-19 | DA Davidson | Buy | Maintains | |
| 2015-05-21 | JP Morgan | Neutral | Maintains | |
| 2015-05-21 | RBC Capital | Outperform | Maintains | |
| 2014-12-04 | Bank of America | Buy | Maintains | |
| 2014-12-04 | DA Davidson | Buy | Maintains | |
| 2014-08-21 | JP Morgan | Neutral | Maintains | |
| 2014-05-22 | DA Davidson | Buy | Maintains | |
| 2014-05-20 | Summit Research Partners | Hold | Buy | Upgrade |
| 2014-02-20 | Bank of America | Buy | Maintains | |
| 2014-02-20 | DA Davidson | Buy | Maintains | |
| 2014-01-30 | JP Morgan | Overweight | Neutral | Downgrade |
| 2013-08-22 | DA Davidson | Buy | Maintains | |
| 2013-07-30 | Pacific Crest | Outperform | Initiate | |
| 2013-05-23 | DA Davidson | Buy | Maintains | |
| 2013-02-21 | DA Davidson | Buy | Maintains | |
| 2012-08-23 | JP Morgan | Overweight | Maintains | |
| 2012-08-23 | Bank of America | Buy | Maintains | |
| 2025-07-25 | Rosenblatt | Buy | Buy | Maintains |
| 2025-09-03 | Keybanc | Overweight | Overweight | Maintains |
| 2025-07-16 | B of A Securities | Buy | Buy | Maintains |
| 2025-05-29 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2025-05-29 | Needham | Buy | Buy | Reiterate |
| 2025-05-29 | Rosenblatt | Buy | Buy | Maintains |
| 2025-05-20 | Keybanc | Overweight | Overweight | Maintains |
| 2025-07-10 | Goldman Sachs | Buy | Initiate | |
| 2025-07-10 | Keybanc | Overweight | Overweight | Maintains |
| 2025-08-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-07-15 | Needham | Buy | Buy | Maintains |
| 2025-07-21 | Piper Sandler | Overweight | Overweight | Maintains |
